Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...

Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...